Semler Scientific (SMLR) has disclosed a new risk, in the Regulation category.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Semler Scientific faces potential business risks due to its dependency on key suppliers for manufacturing its proprietary medical devices. Supply chain disruptions or a failure to maintain these critical supplier relationships could lead to production delays, increased costs, or inability to meet customer demand. Such challenges may adversely affect the company’s financial performance and market competitiveness. Additionally, reliance on a limited number of suppliers heightens the impact of any single supplier’s operational or financial instability.
Overall, Wall Street has a Moderate Buy consensus rating on SMLR stock based on 1 Buy.
To learn more about Semler Scientific’s risk factors, click here.